The Medicines Company announced on Feb. 4, 2015 that it acquired all of the outstanding equity of Annovation Biopharma, a company creating anesthetics to address procedural and general sedation, for an undisclosed amount. Annovation is developing ABP-700 based on technology licensed fromOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.